Literature DB >> 10429648

Immunohistochemical detection of human telomerase reverse transcriptase in normal mucosa and precancerous lesions of the stomach.

W Yasui1, E Tahara, H Tahara, J Fujimoto, K Naka, J Nakayama, F Ishikawa, T Ide, E Tahara.   

Abstract

Telomerase activity confers cell immortality through stabilization of the chromosome, participating in the development of a majority of human cancers. Human telomerase reverse transcriptase (TERT) has been identified as a catalytic subunit of telomerase, and is overexpressed in most gastric carcinomas. We immunohistochemically examined the expression of TERT in normal gastric mucosa and candidate precancerous lesions such as intestinal metaplasia and adenoma. In non-neoplastic gastric mucosa including intestinal metaplasia and normal fundic mucosa, weak but significant expression of TERT was detected in nuclei of epithelial cells located in the lower two-thirds of the glands (wider than the proliferative zone). The telomerase activity was found in a half of gastric adenomas, whose levels of the activity were about 10% of those in gastric carcinomas. TERT protein was expressed in the nuclei of the adenoma cells at moderate levels, that were not necessarily comparable with the telomerase activities. These findings overall suggest that TERT expression may be one of the prerequisites for telomerase activation in an early stage of stomach carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10429648      PMCID: PMC5926124          DOI: 10.1111/j.1349-7006.1999.tb00787.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  26 in total

Review 1.  Telomerases.

Authors:  E H Blackburn
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

2.  Control of telomere length by the human telomeric protein TRF1.

Authors:  B van Steensel; T de Lange
Journal:  Nature       Date:  1997-02-20       Impact factor: 49.962

3.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

4.  Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas.

Authors:  J Nakayama; H Tahara; E Tahara; M Saito; K Ito; H Nakamura; T Nakanishi; E Tahara; T Ide; F Ishikawa
Journal:  Nat Genet       Date:  1998-01       Impact factor: 38.330

5.  Tankyrase, a poly(ADP-ribose) polymerase at human telomeres.

Authors:  S Smith; I Giriat; A Schmitt; T de Lange
Journal:  Science       Date:  1998-11-20       Impact factor: 47.728

6.  Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene.

Authors:  K Yanagihara; T Seyama; M Tsumuraya; N Kamada; K Yokoro
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

7.  Specific association of human telomerase activity with immortal cells and cancer.

Authors:  N W Kim; M A Piatyszek; K R Prowse; C B Harley; M D West; P L Ho; G M Coviello; W E Wright; S L Weinrich; J W Shay
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

8.  p53 mutations in the non-neoplastic mucosa of the human stomach showing intestinal metaplasia.

Authors:  A Ochiai; Y Yamauchi; S Hirohashi
Journal:  Int J Cancer       Date:  1996-02-20       Impact factor: 7.396

9.  Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions.

Authors:  H Tahara; H Kuniyasu; H Yokozaki; W Yasui; J W Shay; T Ide; E Tahara
Journal:  Clin Cancer Res       Date:  1995-11       Impact factor: 12.531

10.  Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinomas.

Authors:  W Yasui; H Tahara; E Tahara; J Fujimoto; J Nakayama; F Ishikawa; T Ide; E Tahara
Journal:  Jpn J Cancer Res       Date:  1998-11
View more
  6 in total

1.  Differences in telomerase activity between colon and rectal cancer.

Authors:  Georgios D Ayiomamitis; George Notas; Apostolos Zaravinos; Adamantia Zizi-Sermpetzoglou; Maria Georgiadou; Ourania Sfakianaki; Elias Kouroumallis
Journal:  Can J Surg       Date:  2014-06       Impact factor: 2.089

Review 2.  Cellular and molecular aspects of gastric cancer.

Authors:  Malcolm-G Smith; Georgina-L Hold; Eiichi Tahara; Emad-M El-Omar
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

3.  The expression of hTERT mRNA and cellular immunity in gastric cancer and precancerosis.

Authors:  Xi-Xian Yao; Lei Yin; Zhong-Cheng Sun
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

4.  Expression of NF-kappaB and human telomerase reverse transcriptase in gastric cancer and precancerous lesions.

Authors:  Wei Wang; He-Sheng Luo; Bao-Ping Yu
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

5.  High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma.

Authors:  E Hiyama; H Yamaoka; T Matsunaga; Y Hayashi; H Ando; S Suita; H Horie; M Kaneko; F Sasaki; K Hashizume; A Nakagawara; N Ohnuma; T Yokoyama
Journal:  Br J Cancer       Date:  2004-08-31       Impact factor: 7.640

Review 6.  Toward the use of precision medicine for the treatment of head and neck squamous cell carcinoma.

Authors:  Wang Gong; Yandi Xiao; Zihao Wei; Yao Yuan; Min Qiu; Chongkui Sun; Xin Zeng; Xinhua Liang; Mingye Feng; Qianming Chen
Journal:  Oncotarget       Date:  2017-01-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.